Biocon's clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO Clinpharm. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocons-Clingene-SIRO-Clinpharm-in-alliance-talks/articleshow/5502878.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocons-Clingene-SIRO-Clinpharm-in-alliance-talks/articleshow/5502878.cmsTue, 26 Jan 2010 20:17:07 GMTBiocon's Clingene, SIRO Clinpharm in alliance talksBiocon's Clingene, SIRO Clinpharm in alliance talks

Biocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investment in Malaysia's biotechnology industry. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-LTD-signs-MoU-with-Malaysian-based-BiotechCorp-/articleshow/5489564.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-LTD-signs-MoU-with-Malaysian-based-BiotechCorp-/articleshow/5489564.cmsFri, 22 Jan 2010 15:42:03 GMTBiocon LTD signs MoU with Malaysian-based BiotechCorp Biocon LTD signs MoU with Malaysian-based BiotechCorp

Reliance Life Sciences (RLS), a company promoted by Reliance Industries’ chairman, Mukesh Ambani, is looking at biopharmaceuticals as a huge thrust area. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Reliance-Life-Sciences-bets-big-on-biosimilars/articleshow/5360256.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Reliance-Life-Sciences-bets-big-on-biosimilars/articleshow/5360256.cmsSun, 20 Dec 2009 20:30:37 GMTReliance Life Sciences bets big on biosimilarsReliance Life Sciences bets big on biosimilars

World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matrix Laboratories, has exited the biotech company by selling its stake to promoters.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Mylan-sells-stake-in-Concord-Biotech/articleshow/5312185.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Mylan-sells-stake-in-Concord-Biotech/articleshow/5312185.cmsMon, 07 Dec 2009 18:38:17 GMTMylan sells stake in Concord BiotechMylan sells stake in Concord Biotech

US firm plans Rs 500 crore unit next to Tata Motors’ project.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Nano-draws-biotech-giant-Alexandria-to-Gujarat/articleshow/5218206.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Nano-draws-biotech-giant-Alexandria-to-Gujarat/articleshow/5218206.cmsWed, 11 Nov 2009 04:56:05 GMTNano draws biotech giant Alexandria to GujaratNano draws biotech giant Alexandria to Gujarat

The US healthcare bill, which has been passed by the US House of Representatives and is awaiting nod from the Senate, holds a lot of promise for generic drug manufacturers from India. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/US-health-bill-to-benefit-local-generic-firms/articleshow/5213728.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/US-health-bill-to-benefit-local-generic-firms/articleshow/5213728.cmsMon, 09 Nov 2009 19:34:09 GMTUS health bill to benefit local generic firmsUS health bill to benefit local generic firms

The Union Department of Science and Technology (DST) has embarked on several projects that are meant to go beyond social relevance. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Lab-to-enterprise-solutions/articleshow/5193420.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Lab-to-enterprise-solutions/articleshow/5193420.cmsTue, 03 Nov 2009 15:09:27 GMTLab to enterprise solutionsLab to enterprise solutions

Pune-based research company Indus Biotech has received approval from the US Food and Drug Administration for clinical trails of its molecule, IND02, which can be used to treat AIDS and will begin the phase 1 trials in the US shortly, its MD Sunil Bhaskaran says.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indus-AIDS-molecule-gets-approval-for-clinical-trials/articleshow/5166064.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Indus-AIDS-molecule-gets-approval-for-clinical-trials/articleshow/5166064.cmsMon, 26 Oct 2009 18:30:41 GMTIndus’ AIDS molecule gets approval for clinical trialsIndus’ AIDS molecule gets approval for clinical trials

The Chennai-based Sanmar Group on Tuesday announced the sale of the closely held Bangalore Genei (India) (BGIP) to Merck Specialities.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Merck-acquires-Sanmar-biz-in-Bangalore/articleshow/5120257.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Merck-acquires-Sanmar-biz-in-Bangalore/articleshow/5120257.cmsTue, 13 Oct 2009 11:20:40 GMTMerck acquires Sanmar biz in BangaloreMerck acquires Sanmar biz in Bangalore

Merck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specialities Pvt Ltd. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Merck-KGaA-acquires-Bangalore-based-bioscience-company/articleshow/5119370.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Merck-KGaA-acquires-Bangalore-based-bioscience-company/articleshow/5119370.cmsTue, 13 Oct 2009 08:44:17 GMTMerck KGaA acquires Bangalore-based bioscience companyMerck KGaA acquires Bangalore-based bioscience company

Biocon Ltd, India's top listed biotechnology firm, said on Wednesday the firm would acquire the bulk pharmaceutical business undertaking of IDL Specialty Chemicals Ltd, located near Hyderabad. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-to-buy-pharma-biz-of-IDL-Specialty/articleshow/5073216.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-to-buy-pharma-biz-of-IDL-Specialty/articleshow/5073216.cmsWed, 30 Sep 2009 15:19:28 GMTBiocon to buy pharma biz of IDL SpecialtyBiocon to buy pharma biz of IDL Specialty

Biotech major Biocon on Friday entered into a strategic tie-up with the US-based Amylin Pharmaceuticals to jointly produce a peptide hybrid molecule for treating diabetes. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-US-firm-to-jointly-make-drug-for-diabetes/articleshow/5000222.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-US-firm-to-jointly-make-drug-for-diabetes/articleshow/5000222.cmsFri, 11 Sep 2009 14:44:09 GMTBiocon, US firm to jointly make drug for diabetesBiocon, US firm to jointly make drug for diabetes

The worrying development, according to WHO, has seen 12 countries, including China and Singapore, reporting a mutation in the virus. India has not reported the mutation so far. http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Drug-resistant-H1N1-reported-in-12-countries/articleshow/4953075.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Drug-resistant-H1N1-reported-in-12-countries/articleshow/4953075.cmsMon, 31 Aug 2009 01:30:05 GMTDrug-resistant H1N1 reported in 12 countriesDrug-resistant H1N1 reported in 12 countries

Biocon Ltd, India's top listed biotechnology firm, expects its branded formulations business in India to double this fiscal year as it launches new products, its chairman said.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-India-biz-growth-boost-from-Mylan-pact/articleshow/4935449.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/Biocon-sees-India-biz-growth-boost-from-Mylan-pact/articleshow/4935449.cmsWed, 26 Aug 2009 04:47:20 GMTBiocon sees India biz growth, boost from Mylan pactBiocon sees India biz growth, boost from Mylan pact

Buddhadeb Bhattacharjee, commerce & industry minister Nirupam Sen and finance minister Asim Dasgupta discussed the land-lease agreement of Nayachara island, where a mega chemical hub is proposed to come up.http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/APCRPL-plans-chemical-hub-at-Nayachara-island/articleshow/4916115.cmshttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/biotech/APCRPL-plans-chemical-hub-at-Nayachara-island/articleshow/4916115.cmsThu, 20 Aug 2009 15:34:20 GMTAPCRPL plans chemical hub at Nayachara islandAPCRPL plans chemical hub at Nayachara island